RVRC
Revium Rx.
$1.67
+0.00 (+0.00%)
At close · Jul 7
Market Cap
$101.42M
Shares
60,729,100
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$1.67
Open$1.67
Day$1.67–1.67
52W$0.50–1.67
Avg vol 30d0
DataJan 2020–Jul 2026
Filing10-Q · May 14
Equibles Rating
blended score · not investment advice
Overall
Buy
SellHoldBuy
Technical
Neutral
Momentum
Very Strong
Sentiment
Neutral
Fundamentals
Fair
Quant / Vol
Low
Market backdrop
VIX 16.9 · calm
Equity put/call 0.86
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+40%
above
Price vs 50-day avg
0%
above
RSI (14)
100
overbought
MACD trend
Negative
52-week position
100%
near high
Momentum
relative strength
1-month return
0%
trailing
6-month return
+11%
trailing
YTD return
+221%
this year
Relative strength
+4%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $2 › 200d $1 — 50d above 200d
Institutional flow
Flat
No 13F holder data
Insider flow
Flat
No net insider activity over 90 days
Short interest
Flat
No short-interest data
Volume signal
Normal
Volume near normal
Institution breadth
Steady
No 13F holder history
Fundamentals
EPS growth
−450%
Y/Y
Balance sheet
$1.7M
net cash
Quant / Vol
risk profile
Volatility
189%
annualized · 1-yr
Max drawdown
0%
past year
ATR
0.0%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 14, 2026
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+40%
Bullish
Price vs 50-day avg
0%
Neutral
RSI (14)
100
Bearish
MACD trend
Negative
Bearish
52-week position
100%
Bullish
Market signals — smart money & positioning
No clear signal
Trend (MA cross)
No cross
50d $2 › 200d $1 — 50d above 200d
Institutional flow
Flat
No 13F holder data
Insider flow
Flat
No net insider activity over 90 days
Short interest
Flat
No short-interest data
Volume signal
Normal
Volume near normal
Institution breadth
Steady
No 13F holder history
Price context
position in its 52-week range
52-wk low $1
Now $2 · 100%
52-wk high $2
vs 200-day avg +40%
vs 50-day avg +0%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Health Information Services — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
RVRC
this stock
Revium Rx.
|
$101.42M | +221.2% | — | — | — |
|
VEEV
Veeva Systems Inc
|
$30.70B | -13.9% | +28.1% | 33.5 | 4.6% |
|
PMDIY
Pro Medicus Ltd./ADR
|
$15.67B | -9.4% | — | — | 0.0% |
|
BTSG
BrightSpring Health Services, Inc.
|
$13.67B | +88.3% | -0.4% | 50.4 | 4.8% |
|
TEM
Tempus AI, Inc.
|
$10.79B | +1.8% | +65.8% | — | 21.2% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| RVRC | +0.0% | +0.0% | +11.3% | +0.0% | +221.2% |
| SPY | +0.9% | +1.4% | +7.6% | +0.1% | +9.7% |
| vs SPY | -0.9% | -1.4% | +3.8% | -0.1% | +211.5% |